Skip to main content

CITADEL ADVISORS LLC

Position in INDV — Indivior Pharmaceuticals, Inc.

CIK 1423053 MIAMI, FL

Position in INDV

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$109,460,941
+$524,081 QoQ
Shares Held
2,667,827
-25.4% QoQ
Ownership
2.26%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#13
of 337 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in INDV Over Time

Shares Held

Position Value (USD)

Derivatives in INDV

reported options exposure · as of Jun 30, 2026
CallValue
$4,821,025
CallShares
117,500
PutValue
$3,434,211
PutShares
83,700

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $1,255,121,114 across 64 Drug Manufacturers - Specialty & Generic names. INDV ranks #5 (8.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 INDV
Indivior Pharmaceuticals, Inc.
This page
2,667,827 $109,460,941

All Filings in INDV

Export CSV
6 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,821,025 117,500
2026-06-30 $3,434,211 83,700
2026-06-30 $109,460,941 2,667,827
2026-03-31 $1,749,552 57,400
2026-03-31 $2,243,328 73,600
2026-03-31 $108,936,860 3,574,044